Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Boon

Showing results (151-160 of 292) with videos related to

Pageof 30
Sort By:
Plos One|July 4, 2017
Systemic complement activation in central serous chorioretinopathyElon H C van Dijk, Roula Tsonaka, Ngaisah Klar-Mohamad, et al.
Journal of Clinical Medicine|August 26, 2022
European Prevalence of Polypoidal Choroidal Vasculopathy: A Systematic Review, Meta-Analysis, and Forecasting StudyElon H C van Dijk, Jeppe K Holtz, Marc J Sirks, et al.
Retina (Philadelphia, Pa.)|October 26, 2023
BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC RETINAL LAYER FEATURES IDENTIFIED BY ARTIFICIAL INTELLIGENCE PREDICT THE COURSE OF CENTRAL SEROUS CHORIORETINOPATHYLorenzo Ferro Desideri, Rodrigo Anguita, Lieselotte E Berger, et al.
The Netherlands Journal of Medicine|February 19, 2019
Diagnosis and treatment of C3 glomerulopathy in a center of expertiseJ J E Koopman, Y K O Teng, C J F Boon, et al.
Progress in Retinal and Eye Research|May 4, 2024
Mitochondrial retinopathies and optic neuropathies: The impact of retinal imaging on modern understanding of pathogenesis, diagnosis, and managementEnrico Borrelli, Francesco Bandello, Camiel J F Boon, et al.
International Journal of Retina and Vitreous|June 1, 2024
Analysis of optical coherence tomography biomarker probability detection in central serous chorioretinopathy by using an artificial intelligence-based biomarker detectorLorenzo Ferro Desideri, Rodrigo Anguita, Lieselotte E Berger, et al.
Genes|May 25, 2024
Mutations in <i>NSUN3</i>, a Mitochondrial Methyl Transferase Gene, Cause Inherited Optic NeuropathyCansu de Muijnck, Jacoline B Ten Brink, Hugoline G de Haan, et al.
Investigative Ophthalmology & Visual Science|October 4, 2023
CRB1-Associated Retinal Dystrophy Patients Have Expanded Lewis Glycoantigen-Positive T CellsLude Moekotte, Jonas J W Kuiper, Sanne Hiddingh, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 6, 2022
Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3Helena M A Feenstra, Elon H C van Dijk, Thomas J van Rijssen, et al.
Retina (Philadelphia, Pa.)|December 10, 2019
GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHYDanial Mohabati, Rosa L Schellevis, Elon H C van Dijk, et al.
Pageof 30

Showing results (151-160 of 292) with videos related to

Sort By:
Pageof 30
Plos One|July 4, 2017
Systemic complement activation in central serous chorioretinopathyElon H C van Dijk, Roula Tsonaka, Ngaisah Klar-Mohamad, et al.
Journal of Clinical Medicine|August 26, 2022
European Prevalence of Polypoidal Choroidal Vasculopathy: A Systematic Review, Meta-Analysis, and Forecasting StudyElon H C van Dijk, Jeppe K Holtz, Marc J Sirks, et al.
Retina (Philadelphia, Pa.)|October 26, 2023
BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC RETINAL LAYER FEATURES IDENTIFIED BY ARTIFICIAL INTELLIGENCE PREDICT THE COURSE OF CENTRAL SEROUS CHORIORETINOPATHYLorenzo Ferro Desideri, Rodrigo Anguita, Lieselotte E Berger, et al.
The Netherlands Journal of Medicine|February 19, 2019
Diagnosis and treatment of C3 glomerulopathy in a center of expertiseJ J E Koopman, Y K O Teng, C J F Boon, et al.
Progress in Retinal and Eye Research|May 4, 2024
Mitochondrial retinopathies and optic neuropathies: The impact of retinal imaging on modern understanding of pathogenesis, diagnosis, and managementEnrico Borrelli, Francesco Bandello, Camiel J F Boon, et al.
International Journal of Retina and Vitreous|June 1, 2024
Analysis of optical coherence tomography biomarker probability detection in central serous chorioretinopathy by using an artificial intelligence-based biomarker detectorLorenzo Ferro Desideri, Rodrigo Anguita, Lieselotte E Berger, et al.
Genes|May 25, 2024
Mutations in <i>NSUN3</i>, a Mitochondrial Methyl Transferase Gene, Cause Inherited Optic NeuropathyCansu de Muijnck, Jacoline B Ten Brink, Hugoline G de Haan, et al.
Investigative Ophthalmology & Visual Science|October 4, 2023
CRB1-Associated Retinal Dystrophy Patients Have Expanded Lewis Glycoantigen-Positive T CellsLude Moekotte, Jonas J W Kuiper, Sanne Hiddingh, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 6, 2022
Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3Helena M A Feenstra, Elon H C van Dijk, Thomas J van Rijssen, et al.
Retina (Philadelphia, Pa.)|December 10, 2019
GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHYDanial Mohabati, Rosa L Schellevis, Elon H C van Dijk, et al.
Pageof 30